230 results
Page 4 of 12
8-K
EX-10.1
t9wfvwttui 8kkk3
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
w4c71eb61cacem
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
EX-10.2
3ezrg7adu7
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-10.1
coa8d zpv
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
424B5
3nyj9xrj1hh ro5ia5ho
28 Feb 20
Prospectus supplement for primary offering
1:27pm
424B5
3wy054 cg3q
31 Jan 20
Prospectus supplement for primary offering
8:03am
8-K
EX-10.1
70aw7mtypp9x6z5a7
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
424B5
u9sbz 4w4
31 Jan 20
Prospectus supplement for primary offering
8:01am
424B5
9k1d45 yv
31 Oct 19
Prospectus supplement for primary offering
4:05pm
424B5
t4o 7cmd8eohx8
31 Oct 19
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
90a3dieq7sg94k
31 Oct 19
Entry into a Material Definitive Agreement
9:29am
8-K
EX-99.1
315j5ck
30 Oct 19
Cocrystal Pharma, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:09pm
424B5
el89soaf
30 Oct 19
Prospectus supplement for primary offering
4:59pm
8-K
EX-1.1
7fbr1ulysu8
30 Oct 19
Entry into a Material Definitive Agreement
4:38pm